Median Arcuate Ligament Syndrome Masked by Cannabis Hyperemesis Syndrome: A Case Report - Scorecard - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Median Arcuate Ligament Syndrome Misdiagnosed as Cannabis Hyperemesis Syndrome: A Case Study

  • September 15, 2026

Share

Clinical Scorecard: Median Arcuate Ligament Syndrome Misdiagnosed as Cannabis Hyperemesis Syndrome: A Case Study

At a Glance

Category

Detail

Condition

Median Arcuate Ligament Syndrome (MALS)

Key Mechanisms

Compression of the celiac artery by the median arcuate ligament, leading to diminished blood flow to foregut organs.

Target Population

Predominantly women aged 30 to 50 years, with a female-to-male ratio of 4:1.

Care Setting

Emergency department and outpatient vascular surgery follow-up.

Key Highlights

  • MALS can be misdiagnosed due to symptom overlap with more common gastrointestinal disorders.

  • Symptoms include postprandial epigastric pain, nausea, vomiting, and unintended weight loss.

  • Diagnostic approaches include mesenteric duplex ultrasound, CT angiography, and MRI angiography.

  • Laparoscopic decompression is a common management option, though not standardized.

  • Greater awareness of MALS is needed to reduce diagnostic delays.

Guideline-Based Recommendations

Diagnosis

  • Diagnosis of MALS is often a diagnosis of exclusion due to nonspecific symptoms.

Management

  • Laparoscopic decompression involving MAL release and celiac ganglionectomy is commonly preferred.

Monitoring & Follow-up

  • Follow-up imaging may be necessary to assess for symptom recurrence or complications.

Risks

  • Surgical intervention risks include complications related to laparoscopic procedures.

Patient & Prescribing Data

Patients with MALS may present with recurrent gastrointestinal symptoms.

Management options are limited for patients who decline surgery or are pregnant.

Clinical Best Practices

  • Consider MALS in patients with recurrent gastrointestinal symptoms and atypical presentations.

  • Utilize appropriate imaging modalities to confirm diagnosis.

Related Resources & Content

  1. Frontiers in Medicine, 2026 -- The interplay of maturity-onset diabetes of the young, obesity, uncontrolled hypertension, and cannabinoid hyperemesis in the progression to end-stage renal disease: a case report

  2. MDSpire News -- CVS Diagnosis and Management: AGA Provides Comprehensive Update

  3. Management of Surgical Interventions for Celiac Artery and Superior Mesenteric Artery Compression Syndromes

  4. Surgical Endoscopy -- Impact of preoperative cannabis use on outcomes following surgical intervention for gastroparesis

  5. European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins

  6. Cannabinoid Hyperemesis Syndrome

  7. European Society for Vascular Surgery (ESVS) 2025 Clinical Practice Guidelines on the Management of Diseases of the Mesenteric and Renal Arteries and Veins☆

Original Source(s)

Related Content